Literature DB >> 15521845

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.

S Rodriguez-Stanley1, A A Ciociola, S Zubaidi, H M Proskin, P B Miner.   

Abstract

BACKGROUND: The rapid onset and symptomatic response to histamine-2 receptor antagonists prior to the pharmacological effect on acid secretion suggests a different mechanism of action. AIM: To determine if ranitidine decreases oesophageal sensitivity to chemical and mechanical stimulation, potentially via oesophageal histamine receptors.
METHODS: A total of 18 patients with functional heartburn received oral ranitidine 150 mg b.d. or placebo for 7 consecutive days in a double-blind randomized crossover design and underwent Barostat balloon distention and Bernstein acid infusion on study day 1 (90 min postdose) and study day 7. First sensation and pain were recorded and pain severity was rated on a 5-point Likert scale and a 100 mm visual analogue scale. Least square mean values were generated and one-tailed t-tests were performed.
RESULTS: After a single dose of ranitidine 150 mg, time to pain with oesophageal acid infusion was increased by 29% (P < 0.05) and visual analogue scale and Likert scores were decreased by 20% (P < 0.06) and 23% (P < 0.02), respectively compared with placebo. After 1 week of ranitidine, positive alterations in sensory parameters persisted. Balloon distention sensory parameters were not altered by ranitidine.
CONCLUSIONS: Ranitidine significantly decreased oesophageal sensitivity to acid. Failure of ranitidine to improve balloon sensory parameters supports existence of multiple sensory pathways in the oesophagus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521845     DOI: 10.1111/j.1365-2036.2004.02217.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 2.  Histamine2-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing.

Authors:  Johnson W McRorie; James A Kirby; Philip B Miner
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

3.  Functional heartburn.

Authors:  Ram Dickman; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

4.  Update on Functional Heartburn.

Authors:  Takahisa Yamasaki; Jessica O'Neil; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

5.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

Review 6.  Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.

Authors:  A Pali S Hungin; Michael Molloy-Bland; Carmelo Scarpignato
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

7.  Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study.

Authors:  Eun Jin Kim; Oh Young Lee; Kang Nyeong Lee; Sung Joon Lee; Jae-Young Jang; Jin Woong Cho; Tae-Oh Kim
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

Review 8.  Reflux Hypersensitivity: A New Functional Esophageal Disorder.

Authors:  Takahisa Yamasaki; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2017-10-30       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.